Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medistim Remuneration Information 2023

Jan 25, 2023

3662_rns_2023-01-25_3c1b3213-2af5-4ad5-97a7-d6a919eb3630.html

Remuneration Information

Open in viewer

Opens in your device viewer

Transfer of shares to CEO

Transfer of shares to CEO

Medistim ASA has transferred 12,000 shares to Medistim CEO Kari E. Krogstad, at

the last traded share price in 2022, of 233.00 NOK per share. This is in

accordance with her compensation agreement with the company, as described in the

Company's Annual Report. After the transfer, Kari E. Krogstad holds a total of

75,802 shares in the company and Medistim ASA holds 75,033 own shares.